Search

Attorney General Wilson Joins Coalition Urging Credit Card Networks to Block Illegal E-Cigarette Sales

South Carolina Attorney General Alan Wilson joined a 13-state coalition in a letter to major credit card networks (Visa, Mastercard, American Express, and Discover) urging them to stop processing payments for illegal e-cigarette products. The coalition states that only 41 e-cigarette products have received FDA authorization for legal sale, while thousands of unauthorized brands continue to sell products generating $11 billion in annual retail sales—representing over 80% of the U.S. e-cigarette market. The AGs argue that payment platforms are already violating their own network rules regarding illegal transactions and high-risk merchant categories by facilitating these sales.

Amneal Magnesium Sulfate IV Bag Recall, Product Mix Up

FDA classified a Class I recall for Amneal Pharmaceuticals' Magnesium Sulfate in Water for Injection (4g/100mL IV bags) after a product mix-up was discovered. A foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" was found to actually contain an IV bag of Tranexamic Acid instead. The affected lot (AH250162, expiration 8/31/2027) comprises 784 cartons distributed nationwide. The recall was initiated by the firm on March 18, 2026, and FDA classified it as Class I on April 13, 2026.

Key Tronic Corporation Cease-and-Desist Order - Inventory Misconduct

The SEC instituted cease-and-desist proceedings against Key Tronic Corporation, CFO Brett R. Larsen, and Senior VP of U.S. Operations Nicholas S. Fasciana for improper expense management at the company's Oakdale, Minnesota manufacturing facility. From approximately July to December 2020, employees generated false entries in the inventory system that falsely indicated inventory was undergoing manufacturing, which inflated inventory value, decreased manufacturing expenses, and improperly increased reported income. Fasciana was aware of and directed portions of this misconduct. The company discovered the scheme via an internal complaint hours before releasing quarterly earnings in January 2021, investigated immediately, and recorded nearly $1 million in corrections. The SEC found violations of Section 21C of the Securities Exchange Act of 1934.

Magellan Diagnostics LeadCare II Blood Lead Test Kit Class II Recall

FDA classified a Class II recall for Magellan Diagnostics LeadCare II Blood Lead Test Kit on April 17, 2026 (Recall No. Z-1893-2026). The firm initiated the field correction on March 13, 2026 after discovering that use of certain third-party micro-collection devices produced false positive blood lead results, which may cause delayed diagnosis and unnecessary additional testing. Approximately 197,893 units were distributed worldwide. The recall does not require product removal from the field.

Teva Isotretinoin 40 mg Superpotent/Subpotent Recall Affects 8,376 Packages

FDA classified a Class II recall by Teva Pharmaceuticals USA, Inc. for Isotretinoin Capsules, USP, 40 mg (NDC 0591-2436-15, 0591-2436-45) after discovering superpotent and subpotent dosage issues in three lots. The recall covers 8,376 packages across lots 100075305 (Exp 06/2027), 100075512 (Exp 07/2027), and 100076103 (Exp 07/2027). Distribution was limited to Florida, Ohio, Puerto Rico, and Mississippi.

Child Predator Section Arrests Fugitive with Gun in Bethlehem

Pennsylvania Attorney General's Child Predator Section arrested Noel A. Tirado, 41, a fugitive from Northampton County, after agents executing a warrant found him hiding under blankets on a child's bed in Bethlehem. Agents discovered a loaded 9mm handgun concealed in a nearby bedroom dresser drawer. Tirado faces charges for manufacturing and possession of child sexual abuse material, possession of a prohibited firearm, and criminal use of a communication facility, with bail set at $1 million cash.

D3 Receptor Agonist Compounds; Methods of Preparation; Intermediates Thereof; and Methods of Use Thereof

EPO published patent application EP3953350A1 for D3 receptor agonist compounds filed by the United States Department of Health and Human Services. The patent covers specific chemical compounds, methods of preparation, intermediates thereof, and methods of therapeutic use.

TCEQ Enforcement Process, Initiation Criteria, and Field Citation Program

TX TCEQ publishes an overview of its enforcement process, describing the phases from violation discovery through enforcement actions including notices of violation, notices of enforcement, and agreed orders. The page links to related policies on enforcement initiation criteria for air, water, and waste violations; field citation procedures offering reduced penalties for eligible violations; evidence protocols for submitting information; and petroleum storage tank certificate revocation procedures.

Biomarker Panel Forecasts Chronic GVHD After Allo-HSCT

NIH registered a single-center observational clinical study (NCT07539220) investigating a biomarker panel for forecasting chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The discovery cohort enrolled 1000 consecutive patients retrospectively from January 2021 to June 2023, while a validation cohort of 500 recipients was enrolled from June 2023 to June 2024. Heparinized blood samples were collected at day +90 post-HSCT and analyzed using multiplex mass spectrometry with pooled plasma to compare proteomic profiles between patients with and without cGVHD.

Miller Road Bridge Closed in Montgomery County Due to Severe Deterioration

PennDOT announced the closure of the Miller Road bridge over West Branch of Perkiomen Creek in Douglass Township, Montgomery County, due to severe deterioration of the wingwall and arch barrel discovered during a recent inspection. The single-span stone masonry arch bridge, built in 1890, carries approximately 154 vehicles per day. PennDOT bridge engineers will develop a repair plan before the roadway can reopen. A detour route via Papermill Road, Lone Pine Road, and Niantic Road has been established.

Axelrod et al v. Lenovo (United States) Inc. - Civil Fraud

Andrew Axelrod and Eliot Burk filed a civil fraud lawsuit against Lenovo (United States) Inc. in the Northern District of California before Judge Jeffrey S. White. The case, based on diversity jurisdiction, was filed August 31, 2021. Recent docket activity as of April 2026 includes administrative motions to seal materials, scheduling disputes, and a discovery letter brief.

WPEngine, Inc. v. Automattic Inc. et al - Trademark Dispute

The United States District Court for the Northern District of California docket shows WPEngine, Inc. filed a trademark civil action against Automattic Inc. on October 2, 2024 (Case 3:24-cv-06917-AMO, Judge Araceli Martínez-Olguín). The most recent filings from April 2026 consist of discovery letter briefs filed by both parties concerning individuals Wittlinger and Zhang.

Tapestry, Inc. et al v. Last Brand, Inc. et al - Trademark Dispute

Tapestry, Inc. and related parties filed a trademark infringement lawsuit against Last Brand, Inc. in the Northern District of California, Oakland Division. The case (4:25-cv-03082-JST) was filed on April 4, 2025, and assigned to Judge Jon S. Tigar. Recent docket activity includes procedural discovery disputes: confidentiality designation motions, discovery letter briefs, and exhibits filed by both parties in April 2026.

Naseri v. United Parcel Service, Inc. - ADA Employment

Sanaz Naseri filed an ADA employment discrimination lawsuit against United Parcel Service, Inc. in the U.S. District Court for the Northern District of California (Case 3:25-cv-09638-RFL). An amended complaint was filed on April 14, 2026, and a stipulated protective order was entered on April 16, 2026, reflecting active discovery proceedings in this federal ADA employment matter.

High Throughput Live-Cell Imaging System - Future Medicines Institute Procurement

Queen's University Belfast has published a Preliminary Market Engagement notice under the Procurement Act 2023 for the supply, delivery, installation, commissioning, and maintenance of a high throughput live-cell imaging system for the Future Medicines Institute. The system is intended to support drug discovery through real-time monitoring of cellular changes. Market engagement responses are due by 13 March 2026, with the full tender notice estimated to publish on 19 April 2026. The estimated contract period is 29 June 2026 to 28 June 2029, with a possible extension to 27 June 2036.

Multiple Vulnerabilities in Apache Kafka Allow Data Breach

CERT-FR issued a security advisory warning of multiple vulnerabilities in Apache Kafka (CVE-2026-33557 and CVE-2026-33558) discovered from the Apache Kafka security bulletin dated 17 April 2026. The vulnerabilities affect Kafka Clients versions 4.0.x prior to 4.0.1, 4.1.x prior to 4.1.2, and versions prior to 3.9.2, as well as Kafka versions 4.1.x prior to 4.1.2. An attacker could exploit these flaws to cause a data confidentiality breach and bypass security policies. Organizations using affected versions should refer to the Apache Kafka CVE list for available patches.

Disciplinary Actions and Citations Search Tool

The Utah Division of Professional Licensing (DOPL) provides a public search tool allowing users to query entity names, license numbers, or individual names to discover disciplinary actions and citations issued by the UT Vet Board and other licensing boards. The search is accessible via db.dpl.utah.gov/disciplinary-actions/. This is an informational tool, not a new regulatory requirement or enforcement action.

Multiple Vulnerabilities in Microsoft Edge (30 CVEs)

CERT-FR issued advisory CERTFR-2026-AVI-0462 alerting to 30 discovered vulnerabilities in Microsoft Edge (CVE-2026-6296 through CVE-2026-6364). Affected versions are those prior to 147.0.3912.72. The risk level is unspecified by Microsoft. Users are directed to apply patches as detailed in Microsoft's security bulletins.

FS-ISAC Sector Risk Advisory on Hardening Cybersecurity Against AI Threats

FS-ISAC published a sector risk advisory with nine recommendations for financial sector organizations on managing cybersecurity and resilience risks from threat actors using artificial intelligence to identify and exploit vulnerabilities. The advisory notes that traditional assumptions and approaches for vulnerability management no longer hold in the face of AI-enabled vulnerability discovery. Recommendations include aggressively remedying known risks and hardening cybersecurity perimeters.

Paknad v. Superior Court - Work Product Waiver in Employment Discrimination Discovery

The California Court of Appeal granted Michelle Paknad's second petition for writ of mandate, ordering the trial court to compel production of investigative reports prepared by attorney Andrea Kelly Smethurst for Intuitive Surgical, Inc. regarding Paknad's sexual harassment and discrimination claims. The court held that Intuitive waived attorney work product protection by asserting the adequacy of its investigations as an affirmative defense, and that Intuitive's proposed redactions—which excised all factual findings—did not preserve valid work product protection.

Court of International Trade Orders CBP and BIS Depositions in Section 232 Steel Tariff Exclusion Case

The U.S. Court of International Trade ordered U.S. Customs and Border Protection and the Bureau of Industry and Security to sit for depositions in a case filed by G&H Diversified Manufacturing LP seeking Section 232 steel tariff refunds. The CIT limited the discovery scope originally sought by G&H but granted access to certain relevant documents, inter-agency communications, exclusion request procedures, and BIS training materials. This marks the first time the CIT has ordered depositions in a case related to the steel Section 232 exclusions process.

Discovery Stayed, Motion to Dismiss Pending, Qualified Immunity

The United States District Court for the District of Colorado granted defendants' motion to stay discovery pending resolution of pending motions to dismiss. The court found that individual defendants' assertion of qualified immunity justified pausing discovery under Supreme Court precedent in Ashcroft v. Iqbal. The plaintiff's amended complaint alleges violations of her Fourth, Fifth, Eighth, and Fourteenth Amendment rights.

USPTO Patent Grant: Bioprobes for Amine Oxidase Enzymes

The USPTO has granted a patent (US12578335B2) to Syntara Limited for novel bioprobes designed to detect and quantify amine oxidase enzymes. These bioprobes are intended for use in assessing enzyme concentrations and inhibition levels in various samples.

Stapled Peptide and Use Thereof Patent Application

The USPTO has published a patent application (US20260085094A1) for a stapled peptide and its use, filed by inventors Zhixiang PAN, Haiying HE, Zhigan JIANG, and Shuhui CHEN. The application details a series of stapled peptides, specifically relating to polypeptides with sequences shown in formulas (I-1)-(I-5) and (II-6), and their pharmaceutically acceptable salts.

USPTO Patent Application: Neuron Generation from Pluripotent Stem Cells

The USPTO has published a patent application (US20260079153A1) detailing methods for generating mature neurons from pluripotent stem cells. The disclosed methods involve overexpressing specific splicing factors to facilitate the study of neurodegenerative diseases and the accelerated derivation of mature neurons.

Bifunctional compounds for degrading BTK via ubiquitin pathway

The USPTO has granted patent US12582722B2 to Nurix Therapeutics, Inc. for bifunctional compounds designed to degrade Bruton's tyrosine kinase (BTK) through the ubiquitin proteolytic pathway. The patent covers novel compounds and pharmaceutical compositions for treating various diseases.

USPTO Patent Application: Sjögren's Syndrome Detection and Treatment

The USPTO has published a patent application detailing methods for detecting and treating Sjögren's syndrome using salivary exosomes. The application, filed by inventors from various institutions, outlines novel diagnostic and therapeutic approaches for the autoimmune disease.

Patent Application: Antibodies Binding Human 4Ig-B7H3

The USPTO has published a new patent application (US20260085122A1) filed by BeOne Medicines I GmbH. The application relates to antibodies or antigen-binding fragments thereof that bind to human 4Ig-B7H3.

Patent Application for Agonistic TNF Receptor Binding Agents

The USPTO has published a new patent application, US20260085126A1, for agonistic TNF receptor binding agents. The application, filed on August 27, 2025, by inventors including Ugur Sahin, details binding agents for TNF superfamily receptors and their potential medical uses.

USPTO Patent Granted for Dissociative Disorder Treatment Methods

The USPTO has granted a patent (US12582616B2) to The Board of Trustees of the Leland Stanford Junior University for methods of treating dissociative disorders. The patent covers agents that modulate neural activity in the posteromedial cortex to treat these conditions.

USPTO Patent Granted for Anti-Pro/Latent Myostatin Antibodies

The USPTO has granted a patent (US12582712B2) to Scholar Rock, Inc. for a method of making anti-pro/latent myostatin antibodies. The patent covers antibodies that specifically bind proMyostatin and/or latent Myostatin and their uses.

USPTO Patent Grant for Tumor Diagnosis and Treatment

The USPTO has granted patent US12583937B2 to Genentech, Inc. for compositions and methods related to the diagnosis and treatment of tumors in mammals. The patent, filed on March 16, 2022, includes 6 claims.

Bi-specific Peptides for Cancer Treatment Granted Patent

The USPTO has granted a patent (US12583888B2) to the University of Tartu for bi-specific peptides designed to target cancer cells and the extracellular matrix. These peptides bind to fibronectin extra domain B (FN-EDB) and/or tenascin-C C domain (TNC-C). The patent was granted on March 24, 2026.

Dru M. Guthrie Reprimanded for Rule Violations

The Idaho State Bar issued a Public Reprimand to attorney Dru M. Guthrie for violating rules of professional conduct, including knowingly disobeying a tribunal's order and failing to comply with discovery requests. The reprimand follows a stipulated resolution where Guthrie admitted to the violations.

BAM Trading Services Inc. - Discovery Schedule Modification

The New Hampshire Banking Department and BAM Trading Services Inc. have jointly filed a motion to modify the discovery schedule in Docket #2025-001. The parties requested and were granted an extension for written discovery responses and a rescheduling of the pre-hearing conference to allow for further investigation and preparation.

Delaware Superior Court Denies Defendant's Motions for New Trial and Discovery

The Delaware Superior Court denied a defendant's motions for a new trial and to compel discovery. The court found the motion for a new trial untimely and lacking in allegations of newly discovered evidence, while the discovery motion was deemed without merit as the state had provided all required discovery.

Commonwealth Real Estate Holdings LLC v. Andersen Tax LLC - Discovery Sanctions

Massachusetts Superior Court sanctioned plaintiffs Commonwealth Real Estate Holdings LLC, Lewis Capital Fund LC, and Henry R. Lewis for discovery violations, ordering them to pay defendants' attorneys' fees. The court found plaintiffs violated Superior Court Rule 30A requirements and Mass. R. Civ. P. 30(b)(6) obligations regarding document production and witness preparation. The violations occurred after plaintiffs failed to produce 25 responsive documents that defendants obtained from third parties.

Fifth Circuit Affirms Dismissal of Employment Discrimination Case

The Fifth Circuit affirmed a district court's decision to dismiss a plaintiff's employment discrimination and retaliation claims with prejudice. The dismissal was based on the plaintiff's counsel's repeated failure to comply with discovery orders and court deadlines over four years of litigation. The court found the dismissal to be a proper exercise of discretion.

State v. Johnson - Criminal Convictions Affirmed

The Oregon Court of Appeals affirmed the convictions of Travis James Douglas Johnson for offenses including using a child in a display of sexually explicit conduct. The court addressed assignments of error regarding discovery violations, denial of substitute counsel, use of electronic restraints, and amendment of the indictment.

People Centre Inc v O'Brien and Ors - Judgment No. 3

The High Court of Ireland issued Judgment No. 3 in the case of People Centre Inc v O'Brien and Ors. This judgment addresses an application by the fourth defendant, Deel Inc, concerning the production of documents, specifically a Termination Agreement. The parties have resolved issues related to redactions and the inspection of certain materials.